Sage Journals: Discover world-class research

Open access

Research article

First published 2020

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

José M. Marín, Luis Mateos, Juan Roldán [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2013-12

The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects

Gregory J. Feldman, Anton Edin

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2014-12

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized,double-blind clinical trials

François Maltais, Sally Singh, Alison C. Donald [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2023-02

In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler

Melanie Hamilton, Martin Anderson, Rajiv Dhand [...]

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Open access

Research article

First published 2015-12

In Vitro Dosing Performance of the ELLIPTA ® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)

Melanie Hamilton, Richard Leggett, Cheng Pang [...]

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Open access

Research article

First published 2020

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2021

Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction

Alessandro Celi, Manuela Latorre, Pierluigi Paggiaro [...]

Sage Open Chronic Disease

Search results

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized,double-blind clinical trials

In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler

In Vitro Dosing Performance of the ELLIPTA ® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction